| dc.contributor.author |
Özkan, Meral |
|
| dc.date.accessioned |
2019-07-24T13:30:19Z |
|
| dc.date.available |
2019-07-24T13:30:19Z |
|
| dc.date.issued |
2018 |
|
| dc.identifier.citation |
Özkan, M. (2018). Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data. Cilt:73, 46-46 ss. |
tr_TR |
| dc.identifier.uri |
http://hdl.handle.net/11616/12915 |
|
| dc.language.iso |
eng |
tr_TR |
| dc.publisher |
Pergamon-elsevıer scıence ltd, the boulevard, langford lane, kıdlıngton, oxford ox5 1gb, england |
tr_TR |
| dc.rights |
info:eu-repo/semantics/restrictedAccess |
tr_TR |
| dc.title |
Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data |
tr_TR |
| dc.type |
article |
tr_TR |
| dc.relation.journal |
Leukemıa research |
tr_TR |
| dc.contributor.department |
İnönü Üniversitesi |
tr_TR |
| dc.identifier.volume |
73 |
tr_TR |
| dc.identifier.startpage |
46 |
tr_TR |
| dc.identifier.endpage |
46 |
tr_TR |